medicare DRG和tw DRG如出一轍，美國hospitalist的困境，何謂POA, HAC?

http://www.medscape.com/viewarticle/724087

https://docs.google.com/fileview?id=0B278nGJMQBk7Y2I2NTZlYmYtOGM2YS00MWY0LWI2NTEtNDgyZWVkNzA0OTE3&hl=zh_TW

美國國會希望medicare是pay for quality,而非pay for quandity
所以做DRG，不付HACs(hospital acquired complications)所以hospitalist在一開始接病人時
就要找出POA(condition present on admission)，病歷書寫至為重要，不然拿不到錢，要想辦法證明自己無罪…(跟台灣怎麼這麼像，要和健保局/法院證明自己無罪，只好像護理系統一樣，文書越來越多，沒空看病人)

他們不太了解，Something just not preventable, blame it to somebody is simple, 簡化加扭曲事情的本質而已
文章裏舉DVT為例
在這裏，老人住院是第一個保齡球瓶倒，明知第一個球瓶倒後面會跟著倒，但健保認為後面的球瓶倒是你幹的你要負責，這是胡搞瞎搞
這些公衛蛋頭copy美國，又嘲笑美國保險制度，全付精力用在壓醫界，一點原創性也沒有，領薪水不知在幹嘛?
好，說我沒醫德，at least i do my job well

神經病一堆!!

留言

張貼留言

這個網誌中的熱門文章

即便是用IGRA, 有時也要等大於三個月才能決定TB contact

圖片
接觸TB後，TST大抵上2-12週轉陽，IGRA大抵上6-10週，但IGRA可以長到3個月以上 TB Tests Can Have a Lengthy Window Period Two studies suggest that interferon- release assay conversion sometimes occurs more than 3 months after exposure to active tuberculosis. Increasingly, interferon- release assays (IGRAs) are being used for diagnosing latent tuberculosis (TB). Although the tuberculin skin test (TST) traditionally used for this purpose converts to positive within 2 to 12 weeks after an individual is exposed to someone with active TB, the interval for IGRA conversion has remained unclear. Current guidelines recommend repeating an initially negative IGRA after 6 to 10 weeks, but this recommendation is not based on controlled studies. Two recent investigations address this issue. Anibarro and colleagues conducted a longitudinal prospective analysis among contacts of TB patients in Spain. The 152 contacts received a TST and an IGRA at first visit; for individuals with negative or conflicting results, t
閱讀完整內容

TG無用論，不用吃fenofibrate了，除非> 500mg/dl

圖片
不用管TG levels，除非高到>500 好好吃東西，好好運動，比吃藥重要!! Don't Miss the New AHA Recommendations on Triglycerides A new scientific statement raises the threshold for pharmacologic treatment of hypertriglyceridemia. The following was published as a "Voices" blog on CardioExchange , an online forum for cardiology news and discussion. The blog prompted a lively conversation, which you can access and join by registering for CardioExchange. I've been surprised at the lack of fanfare surrounding the American Heart Association's recently published scientific statement on triglycerides and cardiovascular disease (CVD). The attention it did receive focused on the lower fasting triglyceride level that is now considered optimal: <100 mg/dL. In my opinion, the real headline was the committee's important statements in support of less drug treatment — in particular, the recommendation for a substantial increase in the triglyceride level that should trigger consideratio
閱讀完整內容